Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) Return on Sales (2020 - 2025)

Historic Return on Sales for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to 4.51%.

  • IceCure Medical's Return on Sales fell 19700.0% to 4.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.18%, marking a year-over-year increase of 12000.0%. This contributed to the annual value of 4.77% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, IceCure Medical's Return on Sales stood at 4.51%, which was down 19700.0% from 6.45% recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Return on Sales registered a high of 12.61% during Q3 2023, and its lowest value of 31.47% during Q4 2022.
  • Its 5-year average for Return on Sales is 2.34%, with a median of 4.91% in 2024.
  • Per our database at Business Quant, IceCure Medical's Return on Sales tumbled by -196700bps in 2022 and then surged by 341900bps in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Return on Sales stood at 11.79% in 2021, then crashed by -167bps to 31.47% in 2022, then skyrocketed by 109bps to 2.72% in 2023, then surged by 90bps to 5.17% in 2024, then fell by -13bps to 4.51% in 2025.
  • Its Return on Sales stands at 4.51% for Q3 2025, versus 6.45% for Q2 2025 and 5.04% for Q1 2025.